Claudia Ainsworth battles recurrent Mantle Cell Lymphoma with daily chemo, backed by research, family, and the support of Blood Cancer United.

Lymphoma originates in lymphocytes and is classified into Hodgkin and Non-Hodgkin types, each with unique features and treatment approaches. Early-stage lymphoma is localized, often with a high cure ...

Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...

Named after the 19th-century scientist who first described abnormal masses in the lymph nodes, Hodgkin lymphoma is a cancer of the lymphatic system. Around 10% of lymphoma diagnoses are categorized as ...

Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma In the POLARIX study (ClinicalTrials.gov identifier: NCT03274492), polatuzumab vedotin plus rituximab, ...

CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases, primarily lupus, systemic sclerosis, and myositis. Up to this point, ulcerative ...

The discovery of a vast telecommunications network that authorities say was capable of wiping out cellular communications in the nation's largest city is just the latest in a steady series of ...

Roberto Alves, with Gov. Ned Lamont, addressing supporters the weekend before his election victory in 2023. Credit: MARK PAZNIOKAS / CTMIRROR.ORG CT Mirror’s independent, nonprofit journalism depends ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...

Earth's mantle is a restless, enigmatic engine that powers volcanism, recycles crust, and regulates the long-term evolution of the planet. But one of its most elusive characteristics—the redox state, ...